Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What metric defines Imax Corporation IMAX success this quarter Q1 2026 Better Than Expected Utilities Select Sector SPDR Fund XLU Top Defensive Play Amid Surging EnergyDriven Inflation Risks MKTW MarketWise delivers strong Q4 2025 profit against projected loss shares rise 132 today Vanguard Energy ETF VDE Poised for Upside Amid Prolonged Elevated Crude Price Environment SoftBank Group Surges 61 Billion in Market Cap Over Two Days on AI Optimism Teradata Chief Product Officer Sells 15000 Shares Insider Transaction Analysis Torrent Pharma Reports 26 Decline in Q4 Profit on Acquisition and Severance Costs Board Approves 5000 Crore QIP Bridgewater Associates Shifts From Enterprise Software to AI Infrastructure Reducing SaaS Positions Jim Cramers Investing Club Highlights Diversification Beyond AI in Monthly Update UnitedHealth Group UNH Gains Hedge Fund Attention as UBS Raises Price Target on Strong Q1 Trends BANX Q4 2022 Earnings EPS Misses Estimates Amid Market Headwinds VELO Q1 2026 Earnings Surprise EPS Beat Drives DoubleDigit Stock Surge OMC Q1 2026 Earnings EPS Beats Estimates by 179 Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady BayFirst Financial Corp BAFN Q1 2026 Earnings Loss Reported Amid Positive Stock Reaction CMCM Q4 2025 Earnings Net Loss Reported Amidst Transition Stock Drops MFS Charter Income Trust MCR Holds Steady Near Support Amid Modest Gains DTE Energy Debenture DTB Holds Steady Near 17 as Bond Market Participants Seek Income MESHW Warrants Hold Steady at 030 Consolidation in Tight Range Amicus Therapeutics FOLD Holds Steady Near Support as Biotech Sector Waits for Catalyst CoreWeave CRWV Edges Higher as Cloud AI Infrastructure Play Holds Key Support CPS Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected PFGC Q1 2026 Earnings EPS Beats Estimates Despite Negative Market Reaction High Tide Inc Q1 2026 Earnings Profitability Surprise as EPS Beats Estimates by 300 MHK Q1 2026 Earnings EPS Surprises on Cost Actions Shares Edge Higher CTO Q1 2026 Earnings Massive EPS Beat as Earnings Surge Past Estimates